Affiliation:
1. Queensland University of Technology
2. Duke NUS Medical School
3. Griffith University
4. Hunter Medical Research Institute
Abstract
Abstract
Purpose
Hip and knee arthroplasties in high income countries are common and costly. A substantial proportion of the costs associated with these surgeries are attributable to the prosthesis chosen by surgeons. The objective of this scoping review was to identify ‘What are the factors influencing surgeons’ prosthesis selection for knee and hip arthroplasty in high-income countries?’
Methods
Four databases of peer reviewed literature (Embase, PubMed, CINAHL, and Web of Science) and two grey literature searches (Policy Commons and Overton) were conducted. Papers were included if they evaluate opinions or experiences of surgeons concerning prosthesis selection for hip or knee arthroplasty and published in English. Factors influencing prosthesis selection were categorised into the domains of patient advantage, surgeon-related, prosthesis quality, vendor or service-related, cost considerations, and information source.
Results
A total of 2572 unique articles were identified and screened, four studies were eligible for inclusion. Consideration of cost and patient benefit were noted across included studies. Several other factors were outlined including familiarity with prostheses, relationship with the vendor, or prosthesis reputation, but the relative extent to which these factors contribute to decision making is unclear.
Conclusion
Despite a relative scarcity of studies investigating factors influencing surgeon’s prosthesis selection choices, multiple factors were identified for further exploration. A greater understanding the perspectives of surgeons is needed for the effective development and implementation of any hospital or system-level policies for reducing arthroplasty costs and improving patient outcomes.
Publisher
Research Square Platform LLC
Reference27 articles.
1. Utilization rates of hip arthroplasty in OECD countries;Pabinger C;Osteoarthritis and cartilage,2014
2. Utilization rates of knee-arthroplasty in OECD countries;Pabinger C;Osteoarthritis and Cartilage,2015
3. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030;Kurtz S;Jbjs,2007
4. Blue Cross Blue Shield. A study of cost variations for knee and hip replacement surgeries in the U.S.; 2015.
5. Private Healthcare Australia. Costing an arm and a leg: Making healthcare more affordable and accessible for Australians. Canberra: PHA; 2015.